Parkinson’s disease is a neurodegenerative disorder that is usually diagnosed in its late stage on the basis of clinical ...

A new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, ...

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, that severely impacts motor and non-motor functions. Early detection and effective ...

ZyVersa CEO Stephen Glover said, “ZyVersa is developing Inflammasome ASC Inhibitor IC 100 for treatment of chronic inflammatory diseases, with ...

As a leader in biotechnological solutions, Creative Biolabs has always been committed to providing innovative products to the scientific research community. SHIRLEY, NY, UNITED STATES, April 23, 2025 ...

The relationship between pathology in the brain and alterations in the gut microbiome could lead to therapies — even if it’s ...

A phase I/II trial showed that transplanting dopaminergic progenitors derived from induced pluripotent stem cells was safe in ...

Space, An Early Frontier. When a brain region is tau-negative by SUVR (green arrow, left), spatial extent (dark blue) correlates better with measures of disease severity than does SUVR (light blue).

For the third year, the Michael J. Fox Foundation organized a concert benefit at Belmont University's Fisher Center for ...

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a study published on ...

A new review highlights growing evidence linking gut health to sleep apnea, suggesting that changes in gut microbiota may influence the severity of sleep-disordered breathing.